Robert E. Gagnon
CFO at Opus Genetics, Inc. (IRD); Director at Verastem, Inc. (VSTM)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $193K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 8SEC | IRDOpus Genetics, Inc. | Sell Plan | 28,000556,375 held (−5%) | $4.54 | $127K | -15.4% |
| Jul 27SEC | IRDOpus Genetics, Inc. | Sell | 7,783584,375 held (−1%) | $2.95 | $23K | +30.2% |
| Apr 27SEC | IRDOpus Genetics, Inc. | Sell | 7,842592,158 held (−1%) | $5.18 | $41K | -25.9% |
| Dec 18SEC | VSTMVerastem, Inc. | Sell Plan | 28341,678 held (−1%) | $9.14 | $3K | -5.4% |
- Sell
CFO Robert E. Gagnon sold $127K of IRD at $4.54 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Robert E. Gagnon sold $3K of VSTM at $9.14 — pre-scheduled 10b5-1 plan sale.